StonvexLoading…
StonvexStonvexStonvexCore line items from PMTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $543.53M | $480.60M | $444.55M | $475.75M |
Operating Income | $54.84M | $62.79M | $61.59M | $79.13M |
Net Income | $14.95M | $19.52M | $23.98M | $36.54M |
EPS (Diluted) | $1.25 | $1.64 | $2.01 | $3.11 |
Total Assets | $403.19M | $349.66M | $293.68M | $296.67M |
Total Liabilities | $420.52M | $385.28M | $345.62M | $378.74M |
Cash & Equivalents | $21.70M | $33.54M | $12.41M | $11.04M |
Free Cash Flow OCF − CapEx | $41.33M | $34.06M | $27.64M | $13.47M |
Shares Outstanding | 11.46M | 11.24M | 11.45M | 11.39M |